5-Day brain zapping trial aims to lift severe depression

NCT ID NCT06895863

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial tests a new, accelerated form of brain stimulation for people with severe depression that hasn't improved with medication. Over five days, 78 participants will receive 25 sessions of magnetic stimulation, either targeting a standard brain area or a new one, or a sham (fake) treatment. The goal is to see if this fast, personalized approach can safely and quickly ease depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
transcranial magnetic stimulation (TMS) using intermittent theta burst stimulation (iTBS)
What this could lead to
If it works, this could offer a fast, non-invasive treatment option for people with severe depression that hasn't responded to medication.
What could go wrong
This is a relatively small, early-stage trial testing two different brain targets. It's not yet proven to work, and the effects may be modest or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depressive Disorder, Treatment-Resistant major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre of Neuropsychiatric Depression Research

    RECRUITING

    Glostrup Municipality, 2600, Denmark

  • Danish Research Centre for Magnetic Resonance

    NOT_YET_RECRUITING

    Hvidovre, 2650, Denmark

  • Mental Health Center North Zealand

    NOT_YET_RECRUITING

    Hilleroed, 3400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.